Trial intelligence / Profile preview

Tranexamic Acid During Cystectomy Trial (TACT)

NCT01869413Phase 3Completed

Sponsor
Ottawa Hospital Research Institute
Start
Jun 2013
Primary completion
Jan 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in postoperative hemorrhage comparing Tranexamic Acid with Placebo control (2 arms). Primary endpoint: Proportion of patients transfused at least one unit of packed red blood cell transfusion. Started Jun 2013; status: completed.

02

Drugs

tranexamic acid
03

Conditions

postoperative hemorrhage

Beyond the preview

Go deeper on NCT01869413.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01869413.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call